U.S. Stock SEC Cash-Flow Directory / Healthcare

EXELAccumulate

Exelixis Inc · Biological Products, (No Diagnostic Substances)

TFE Standardized Verdict
Accumulate
Impersonal model classification
Official SEC Free Cash Flow
$277.5M
SEC Form 10-Q (filed 2026-10-29)
Trend Episodes
Mixed / Stalling
Multi-episode price & volume path
vs. S&P 500 Benchmark
Leading S&P 500
Relative leadership check
Counterpoint — What Independent Investors Should Watch Out For

Normal Volatility & Next-Quarter Cash-Flow Follow-Through

Historical swing check: Exelixis Inc pulled back 12.6% from peak to trough over the past year — ask whether your position size stays comfortable through a similar dip.

3 Plain-English Questions to Ask Before Buying or Holding EXEL:
  • Does EXEL's current valuation leave reasonable upside relative to its $277.5M SEC Free Cash Flow?
  • How large would a position in EXEL make my overall Healthcare concentration?
  • What change in SEC cash flow or trend episodes would cause us to trim or exit?

Official U.S. SEC EDGAR Filing Snapshot (EXEL)

Period Ended 2026-10-02 · Filed 2026-10-29
Revenues
$658.7M
Gross Margin
96.0%
Operating Cash Flow
$280.0M
Capital Spending (CapEx)
$2.5M
Free Cash Flow
$277.5M
Current Ratio
3.21x
Long-Term Debt
$0
Subscriber Research Workbench • Founding 1000 Launch Offer

See All 36 Healthcare Stocks Rated Accumulate Right Now

Every TFE Accumulate stock requires verified positive SEC Free Cash Flow, constructive multi-episode trend durability, and S&P 500 relative strength. Unlock the full 254-stock Accumulate roster, full 2,400+ stock Screener, and personal Watchlist.

Claim Founding 1000 Access — $25 / Full Year →One-time 12-month pass (capped at 1,000 members) · Or $9.99/mo
Check Other Popular U.S. Stocks:
AMZN SEC Checkup →NVDA SEC Checkup →AAPL SEC Checkup →GOOGL SEC Checkup →MSFT SEC Checkup →COST SEC Checkup →PLTR SEC Checkup →KO SEC Checkup →Browse All 2,728 Stocks →

Research Disclosure: Standardized impersonal model publication for research use only — not personalized investment advice and not a brokerage site. Verify all filings and live quotes independently before making investment decisions.